Catalysts for Par Pharmaceutical Inc
47 tracked
Feb 14, 2001
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Mar 29, 2000
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Mar 14, 2000
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Nov 17, 1998
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Sep 5, 1997
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Nov 29, 1994
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Feb 7, 1989
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Jun 11, 1982
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Aug 18, 1980
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Apr 4, 1980
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Apr 4, 1980
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Jul 5, 1977
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
May 16, 1977
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
May 16, 1977
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Jan 28, 1977
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
May 14, 1976
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→
Feb 19, 1970
approval
KETALAR (KETAMINE HYDROCHLORIDE) — FDA approval
Par Pharmaceutical Inc
→